ABT – Clean Technical Setup with Strong Risk/Reward📈 Ticker: NYSE:ABT (Abbott Laboratories)
🕒 Timeframe: Daily
💡 Strategy: Ichimoku + MACD + Risk/Reward Setup
Abbott ( NYSE:ABT ) is showing a compelling long opportunity after a pullback to the Tenkan-sen (conversion line) within the Ichimoku Cloud structure. Price action remains bullish as it res
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
7.8 USD
13.35 B USD
41.95 B USD
1.73 B
About Abbott Laboratories
Sector
Industry
CEO
Robert B. Ford
Website
Headquarters
Abbott Park
Founded
1888
FIGI
BBG00K9Q6546
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the line of branded generic pharmaceuticals manufactured worldwide and marketed and sold outside the United States in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternate care testing sites. The Nutritional Products segment caters to the worldwide sales of pediatric and adult nutritional products. The Medical Devices segment includes a broad line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care and continuous glucose monitoring products, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
ABT Trade Setup: Breakout Play with 10.6% Upside🏥 Abbott Labs (ABT) Trade Alert
Positioning in this healthcare giant as it breaks out from consolidation - here's the strategic play:
📌 Trade Levels
▶ Entry: $133.12 (confirmed above SMA 50)
🎯 Target: $147.21 (+10.6%)
🛑 Stop Loss: $126.00 (-5.3% risk)
⚖️ Risk/Reward: 1:2
Why ABT Now?
✅ Fundamental
ABT long at 126.75 -- bad new is good news (for me)ABT got some bad news today when a Missouri judge ruled there would be a retrlal regarding a court case involving ABT's baby formula, and the stock, which was already down 3 days in a row, got thumped. While I don't dismiss long term risk from that news, I'm not in this for the long haul. I will l
$ABT : Reversal Pattern Just Dropped – Is $115 the NextAlright, let’s check out ABT on the daily chart. The stock enjoyed a steady climb since Jan 2025, riding a clear uptrend line, and now just nailed a technical reversal pattern, and it seems like it’s aiming for a target around $115 per share in the short term (1-3 months).
Abbott Laboratories | ABT | Long at $110.00Abbott Laboratories NYSE:ABT has been making higher highs and lower lows over the last year, potentially signaling a reversal in its downward trend. Monkeypox and the return of cold/flu/COVID season may spark another run to close the price gap on the daily chart around $140. It is currently in a p
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where 0Q15 is featured.
Related stocks
Frequently Asked Questions
The current price of 0Q15 is 135.8 USD — it has decreased by −2.46% in the past 24 hours. Watch ABBOTT LABORATORIES COM NPV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ABBOTT LABORATORIES COM NPV stocks are traded under the ticker 0Q15.
0Q15 stock has fallen by −0.03% compared to the previous week, the month change is a 133.39% rise, over the last year ABBOTT LABORATORIES COM NPV has showed a 138.19% increase.
We've gathered analysts' opinions on ABBOTT LABORATORIES COM NPV future price: according to them, 0Q15 price has a max estimate of 159.00 USD and a min estimate of 127.00 USD. Watch 0Q15 chart and read a more detailed ABBOTT LABORATORIES COM NPV stock forecast: see what analysts think of ABBOTT LABORATORIES COM NPV and suggest that you do with its stocks.
0Q15 reached its all-time high on Apr 24, 2018 with the price of 58.6 USD, and its all-time low was 57.0 USD and was reached on Apr 26, 2018. View more price dynamics on 0Q15 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0Q15 stock is 3.94% volatile and has beta coefficient of 0.27. Track ABBOTT LABORATORIES COM NPV stock price on the chart and check out the list of the most volatile stocks — is ABBOTT LABORATORIES COM NPV there?
Today ABBOTT LABORATORIES COM NPV has the market capitalization of 235.37 B, it has increased by 0.48% over the last week.
Yes, you can track ABBOTT LABORATORIES COM NPV financials in yearly and quarterly reports right on TradingView.
ABBOTT LABORATORIES COM NPV is going to release the next earnings report on Jul 17, 2025. Keep track of upcoming events with our Earnings Calendar.
0Q15 earnings for the last quarter are 1.09 USD per share, whereas the estimation was 1.07 USD resulting in a 1.66% surprise. The estimated earnings for the next quarter are 1.25 USD per share. See more details about ABBOTT LABORATORIES COM NPV earnings.
ABBOTT LABORATORIES COM NPV revenue for the last quarter amounts to 10.36 B USD, despite the estimated figure of 10.41 B USD. In the next quarter, revenue is expected to reach 11.06 B USD.
0Q15 net income for the last quarter is 1.30 B USD, while the quarter before that showed 9.20 B USD of net income which accounts for −85.86% change. Track more ABBOTT LABORATORIES COM NPV financial stats to get the full picture.
Yes, 0Q15 dividends are paid quarterly. The last dividend per share was 0.59 USD. As of today, Dividend Yield (TTM)% is 1.69%. Tracking ABBOTT LABORATORIES COM NPV dividends might help you take more informed decisions.
ABBOTT LABORATORIES COM NPV dividend yield was 1.98% in 2024, and payout ratio reached 29.33%. The year before the numbers were 1.89% and 63.81% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jun 13, 2025, the company has 114 K employees. See our rating of the largest employees — is ABBOTT LABORATORIES COM NPV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ABBOTT LABORATORIES COM NPV EBITDA is 10.35 B USD, and current EBITDA margin is 24.00%. See more stats in ABBOTT LABORATORIES COM NPV financial statements.
Like other stocks, 0Q15 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABBOTT LABORATORIES COM NPV stock right from TradingView charts — choose your broker and connect to your account.